Literature DB >> 1276151

Metabolism of 1,25-dihydroxyvitamin D3: evidence for side-chain oxidation.

R Kumar, D Harnden, H F DeLuca.   

Abstract

Approximately 7% of a 650-pmol dose of 25-hydroxyl[26,27-14C]vitamin D3 and 25% of a 325-pmol dose of 1,25-dihydroxyl[26,27-14C]vitamin D3 are metabolized to 14CO2 by vitamin D deficient rats. Nephrectomy prevents the metabolism of 25-hydroxy[26,27-14C]vitamin D3 to 14CO2 but not that of 1,25-dihydroxy[26,27-14C]vitamin D3. Less than 5% of the 14C from 24,25-dihydroxy[26,27-14C]vitamin D3 is metabolized to 14CO2. Feeding diets high in calcium and supplemented with vitamin D3 markedly diminishes the amount of 14CO2 formed from 25-hydroxy[26,27-14C]vitamin D3 but not that from 1,25-dihydroxyl[26,27-14C]vitamin D3. These results provide strong evidence that only 1-hydroxylated vitamin D compounds and especially 1,25-dihydroxyvitamin D3 undergo side-chain oxidation and cleavage to yield an unknown metabolite and CO2.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1276151     DOI: 10.1021/bi00656a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

Review 2.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

3.  Enhanced sensitivity of young suckling rats to the toxic effects of 1,25-dihydroxyvitamin D3.

Authors:  L A Dostal; S U Toverud
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

4.  Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol.

Authors:  A C Borges; T Feres; L M Vianna; T B Paiva
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Role of vitamin D glucosiduronate in calcium homeostasis.

Authors:  S Nagubandi; R Kumar; J M Londowski; R A Corradino; P S Tietz
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

6.  Production of C-24- and C-23-oxidized metabolites of 1,25-dihydroxycholecalciferol by cultured kidney cells (LLC PK1) and their presence in kidney in vivo.

Authors:  J L Napoli; C A Martin
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

7.  Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation.

Authors:  R Kumar; W R Cohen; P Silva; F H Epstein
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

8.  Biliary excretion of radioactivity after intravenous administration of 3H-1,25-dihydroxyvitamin D3 in man.

Authors:  J E Ledger; G J Watson; C C Ainley; J E Compston
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

9.  Enterohepatic physiology of 1,25-dihydroxyvitamin D3.

Authors:  R Kumar; S Nagubandi; V R Mattox; J M Londowski
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

10.  Preparation of tritium- or deuterium-labeled vitamin D analogs by a convenient general method.

Authors:  H E Paaren; M A Fivizzani; H K Schnoes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.